These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34675526)

  • 21. The impact of family systems and social networks on substance use initiation and recovery among women with substance use disorders.
    Jones AA; Strong-Jones S; Bishop RE; Brant K; Owczarzak J; Ngigi KW; Latkin C
    Psychol Addict Behav; 2024 Dec; 38(8):850-859. PubMed ID: 38661657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hair salons and stylist-client social relationships as facilitators of community-based contraceptive uptake in KwaZulu-Natal, South Africa: a qualitative analysis.
    Wara NJ; Psaros C; Govere S; Dladla N; Stuckwisch A; Zionts D; Jarolimova J; Bassett IV
    Reprod Health; 2021 Aug; 18(1):178. PubMed ID: 34461925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.
    Cochran G; Bruneau J; Cox N; Gordon AJ
    Subst Abus; 2020; 41(3):269-274. PubMed ID: 32697171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A qualitative investigation into the effectiveness of a housing navigator program linking justice-involved clients with recovery housing.
    Dewey JM; Hibbard P; Watson DP; Konchak JN; Hinami K
    Health Justice; 2024 Sep; 12(1):37. PubMed ID: 39276243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.
    Bart GB; Saxon A; Fiellin DA; McNeely J; Muench JP; Shanahan CW; Huntley K; Gore-Langton RE
    Addict Sci Clin Pract; 2020 Jan; 15(1):4. PubMed ID: 31948487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plausibility of patient-centred care in high-intensity methadone treatment: reflections of providers and patients.
    Marshall K; Maina G; Sherstobitoff J
    Addict Sci Clin Pract; 2021 Jun; 16(1):42. PubMed ID: 34187549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of a pharmacist care manager model to expand availability of medications for opioid use disorder.
    DeRonne BM; Wong KR; Schultz E; Jones E; Krebs EE
    Am J Health Syst Pharm; 2021 Feb; 78(4):354-359. PubMed ID: 33326564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder.
    Nayak SM; Huhn AS; Bergeria CL; Strain EC; Dunn KE
    Drug Alcohol Depend; 2021 Apr; 221():108649. PubMed ID: 33640679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of Opioid and Alcohol Pharmacotherapy Initiation at Hospital Discharge Among Patients Seen by an Inpatient Addiction Consult Service.
    Englander H; King C; Nicolaidis C; Collins D; Patten A; Gregg J; Korthuis PT
    J Addict Med; 2020; 14(5):415-422. PubMed ID: 31868830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
    Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
    Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff.
    Andraka-Christou B; Atkins D
    Am J Drug Alcohol Abuse; 2020 Nov; 46(6):749-760. PubMed ID: 32969757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder.
    Randall-Kosich O; Andraka-Christou B; Totaram R; Alamo J; Nadig M
    J Addict Med; 2020; 14(4):e44-e52. PubMed ID: 31651562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of peer recovery support services on stages of the opioid use disorder treatment cascade: A systematic review.
    Gormley MA; Pericot-Valverde I; Diaz L; Coleman A; Lancaster J; Ortiz E; Moschella P; Heo M; Litwin AH
    Drug Alcohol Depend; 2021 Dec; 229(Pt B):109123. PubMed ID: 34700201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Six-month outcomes of the HOPE smartphone application designed to support treatment with medications for opioid use disorder and piloted during an early statewide COVID-19 lockdown.
    Hodges J; Waselewski M; Harrington W; Franklin T; Schorling K; Huynh J; Tabackman A; Otero K; Ingersoll K; Tiouririne NA; Flickinger T; Dillingham R
    Addict Sci Clin Pract; 2022 Mar; 17(1):16. PubMed ID: 35255965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of medications for opioid use disorder (MOUD) on residential treatment completion and retention in the US.
    Stahler GJ; Mennis J
    Drug Alcohol Depend; 2020 Jul; 212():108067. PubMed ID: 32445926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder.
    Friesen EL; Kurdyak P
    Drug Alcohol Depend; 2020 Nov; 216():108244. PubMed ID: 32861134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Designing an "Ideal" Substance Use Disorder Treatment Center: Perspectives of People Who Have Utilized Medications for Opioid Use Disorder.
    Andraka-Christou B; Randall-Kosich O; Totaram R
    Qual Health Res; 2021 Feb; 31(3):512-522. PubMed ID: 33213261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Problematizing the DSM-5 criteria for opioid use disorder: A qualitative analysis.
    Boyd S; Ivsins A; Murray D
    Int J Drug Policy; 2020 Apr; 78():102690. PubMed ID: 32278265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and organizational factors shaping access to medication treatment for opioid use disorder in community supervision.
    Kennedy-Hendricks A; Bandara S; Merritt S; Barry CL; Saloner B
    Drug Alcohol Depend; 2021 Sep; 226():108881. PubMed ID: 34218008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "I'm a Survivor": Perceptions of Chronic Disease and Survivorship Among Individuals in Long-Term Remission from Opioid Use Disorder.
    Pytell JD; Sklar MD; Carrese J; Rastegar DA; Gunn C; Chander G
    J Gen Intern Med; 2022 Feb; 37(3):593-600. PubMed ID: 34027611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.